These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 9102882)

  • 1. [Local defense factors in the peritoneal cavity in patients on chronic peritoneal dialysis].
    Dimković N; Pejnović N; Radovanović Lj
    Srp Arh Celok Lek; 1996; 124 Suppl 1():144-6. PubMed ID: 9102882
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship of IgG, C3 and transferrin with opsonising and bacteriostatic activity of peritoneal fluid from CAPD patients and the incidence of peritonitis.
    McGregor SJ; Brock JH; Briggs JD; Junor BJ
    Nephrol Dial Transplant; 1987; 2(6):551-6. PubMed ID: 3126457
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of dwell time on peritoneal phagocytic defense of chronic peritoneal dialysis patients.
    Vlaanderen K; de Fijter CW; Bos HJ; van der Meulen J; Beelen RH; Oe PL; Verbrugh HA
    Adv Perit Dial; 1989; 5():151-3. PubMed ID: 2577399
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Defense mechanisms in the peritoneum].
    Szczepanik M; Gryglewski A; Solecki R
    Przegl Lek; 1999; 56(3):227-30. PubMed ID: 10442014
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunologic patterns in CAPD patients with peritonitis.
    Lamperi S; Carozzi S
    Clin Nephrol; 1988; 30 Suppl 1():S41-4. PubMed ID: 3052960
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peritoneal dialysis effluent, cytokine levels, and peritoneal mesothelial cell viability in CAPD: a possible relationship.
    Carozzi S; Nasini MG; Ravera M; Sanna A; Tirotta A; Lamperi S
    Adv Perit Dial; 1997; 13():7-12. PubMed ID: 9360642
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peritonitis during continuous ambulatory peritoneal dialysis: the role of host defense mechanisms.
    Keane WF; Peterson PK
    Trans Am Soc Artif Intern Organs; 1984; 30():684-6. PubMed ID: 6533956
    [No Abstract]   [Full Text] [Related]  

  • 8. Opsonic activity of dialysis effluent predicts those at risk of Staphylococcus epidermidis peritonitis.
    Coles GA; Alobaidi HM; Topley N; Davies M
    Nephrol Dial Transplant; 1987; 2(5):359-65. PubMed ID: 3122114
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peritonitis: pathophysiology and local defense mechanisms.
    Heemken R; Gandawidjaja L; Hau T
    Hepatogastroenterology; 1997; 44(16):927-36. PubMed ID: 9261580
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute inflammation in peritoneal dialysis: experimental studies in rats. Characterization of regulatory mechanisms.
    Bazargani F
    Swed Dent J Suppl; 2005; (171):1-57, i. PubMed ID: 15847249
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The role of cytokines in peritoneal dialysis].
    Opatrná S; Topolcan O; Opatrný K
    Vnitr Lek; 2000 Nov; 46(11):794-800. PubMed ID: 15637896
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The relationship between peritoneal leukocyte count, fluid cultures, and clinical results in peritonitis among peritoneal dialysis patients: is there a geographic or ethnic difference?
    Ozturk S; Sar F; Altas K; Uzun S; Yazici H; Bozfakioglu S; Kazancioglu R
    Adv Perit Dial; 2009; 25():32-40. PubMed ID: 19886314
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparing peritonitis in continuous ambulatory peritoneal dialysis patients versus automated peritoneal dialysis patients.
    Locatelli AJ; Marcos GM; Gómez MG; Alvarez SA; DeBenedetti LC
    Adv Perit Dial; 1999; 15():193-6. PubMed ID: 10682100
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Longitudinal study of peritoneal defence mechanisms in patients on continuous ambulatory peritoneal dialysis (CAPD).
    McGregor SJ; Brock JH; Briggs JD; Junor BJ
    Perit Dial Int; 1989; 9(2):115-9. PubMed ID: 2488196
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complement and immunoglobulin levels in serum and ascitic fluid of patients with spontaneous bacterial peritonitis, malignant ascites, and tuberculous peritonitis.
    Yildirim B; Sezgin N; Sari R; Sevinc A; Hilmioglu F
    South Med J; 2002 Oct; 95(10):1158-62. PubMed ID: 12425501
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of intraperitoneal urokinase in acute peritonitis and prevention of catheter loss in peritoneal dialysis patients.
    Gadallah MF; Tamayo A; Sandborn M; Ramdeen G; Moles K
    Adv Perit Dial; 2000; 16():233-6. PubMed ID: 11045301
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The spectrum of peritoneal fibrosing syndromes in peritoneal dialysis.
    Mactier RA
    Adv Perit Dial; 2000; 16():223-8. PubMed ID: 11045299
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peritonitis in continuous ambulatory peritoneal dialysis: cytokines in peritoneal fluid and blood.
    Enríquez J; Klínger J; Arturo JA; Delgado M; Tobar C; Mosquera M
    Adv Perit Dial; 2002; 18():177-83. PubMed ID: 12402614
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mannose binding lectin level and polymorphism in patients on long-term peritoneal dialysis.
    Lam MF; Leung JC; Tang CC; Lo WK; Tse KC; Yip TP; Lui SL; Chan TM; Lai KN
    Nephrol Dial Transplant; 2005 Nov; 20(11):2489-96. PubMed ID: 16115848
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Specific aspects of peritoneal dialysis in diabetic patients].
    Opatrná S; Klaboch J
    Vnitr Lek; 2008 May; 54(5):523-9. PubMed ID: 18630640
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.